The future of CBD.
The clinical infrastructure cannabinoids always needed.
Not a supplement. A clinical pathway.
Licensed clinicians. Real prescriptions. Pharmacy‑compounded, THC‑free formulations.
This is not medical marijuana.
Prescription Cannabinoid Care is a distinct clinical pathway: non‑intoxicating, THC‑free cannabinoid formulations, compounded by a licensed pharmacy and prescribed by licensed clinicians. No marijuana card. No intoxication. By design.
Four pillars that make it care.
Every patient begins with a licensed clinician assessment — health history, medications, and goals reviewed before any decision.
Therapy is authorized through a clinician prescription, not a retail purchase — the clinical gate that separates this from the consumer market.
Formulations are prepared by a licensed 503A compounding pharmacy, specific to the prescription issued.
The whole pathway is delivered through secure, HIPAA‑compliant telehealth — no waiting rooms, no referrals.
Five things a clinician reviews before any care decision.
Conditions, diagnoses, and relevant background that shape your care protocol.
Active prescriptions reviewed for contraindications before any recommendation.
What you’re experiencing, how long, and what a meaningful outcome looks like for you.
What you’ve already tried — including OTC products — and how your body responded.
Individual fit is assessed, not assumed. Prescription decisions are clinician‑guided.
Retail is made for the average consumer.
Yours is made for a specific prescription.
Compounded to your clinician’s instructions — not manufactured for a market.
Prepared for you, to pharmaceutical standards.
Each formulation is prepared exactly to the prescribing clinician’s instructions.
Prepared under USP‑grade protocols — the same standards applied to licensed pharmaceuticals.
Every stage of preparation, review, and dispensing is supervised by a licensed pharmacist.
Ships directly to you after your prescription is received — no pharmacy visit required.
All Cope Now formulations are non‑intoxicating. No THC — by clinical design, not accident.
Guided by board-certified physicians.
Questions patients ask.
No. It is not medical marijuana. It involves non‑intoxicating, THC‑free cannabinoid formulations compounded by a licensed pharmacy. You do not obtain a marijuana card through Cope Now — this is a distinct clinical pathway evaluated and prescribed by licensed clinicians.
No. Prescribing decisions are made by the licensed clinician based on your individual evaluation. Cope Now facilitates access to clinical evaluation; whether cannabinoid therapy is appropriate is decided by your clinician, not the platform.
Retail CBD is sold as a dietary supplement without clinician evaluation, prescription authorization, or pharmacy oversight. Prescription Cannabinoid Care requires a licensed clinician evaluation first; if prescribed, formulations are prepared by a licensed 503A compounding pharmacy — not manufactured as a consumer supplement.
Cope Now does not treat conditions. Licensed clinicians evaluate patients who present with specific health concerns and determine whether cannabinoid therapy is an appropriate adjunctive option. Clinicians currently evaluate for anxiety, sleep, pain, and recovery, at their discretion.
Yes. This is a prescription drug product tailored to you. It is safe to take on a plane, as with any other prescription drug product.
See if you’re eligible — it’s free.
A short screening confirms the basics. If you move forward, a licensed clinician decides whether Prescription Cannabinoid Care fits you. A prescription is never automatic.
Check Your Eligibility